Resultsbee.com

757 Westwood Plaza,Los Angeles,CA

Dr. Behal is an Assistant Clinical Professor of Pediatrics and serves as Medical Director of the Pediatric Pain and Palliative Care Division at UCLA Mattel Children's Hospital. She is triple board-certified in General Pediatrics, Pediatric Hematology/Oncology, and Hospice and Palliative Medicine. Dr. Behal earned her Bachelor of Arts at Georgetown University and received her medical degree at Georgetown University School of Medicine. She completed her pediatric residency at New York-Presbyterian Hospital/Weill Cornell Medical Center in New York City. Thereafter, she completed her fellowship in Pediatric Hematology/Oncology at the combined program between Memorial Sloan Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical Center in New York City. In addition, she completed a second fellowship in Hospice and Palliative Medicine at Memorial Sloan Kettering Cancer Center.Prior to joining the faculty at UCLA, Dr. Behal founded and developed the first formal pediatric palliative care service at New York-Presbyterian Komansky Children's Hospital in New York City. In her current role as Medical Director of Pediatric Pain and Palliative Care at UCLA, she serves on an inter-disciplinary team of healthcare professionals who provide an additional layer of support to pediatric patients and their families who are dealing with the symptoms and stress of serious illness.

(131) 082 - 5086

15503 Ventura Blvd. Suite 150,Encino,CA

Dr Palaskas joined the Encino Cancer Care practice in 2017 and is excited to help fulfill the mission of UCLA in bringing access to clinical trials and academic-center level care to the Encino community. He is a Clinical Instructor of Medicine at the David Geffen School of Medicine at UCLA and clinician-investigator. He completed his Hematology/Oncology fellowship at UCLA and is a graduate of the Specialty Training and Advanced Research Program. Dr Palaskas is a native of the American Midwest but spent many years in Europe, including attending medical school in Thessaloniki, Greece. He trained in Internal Medicine at St Elizabeth?s Medical Center in Boston, a TUFTS University affiliate. Prior to his Fellowship at UCLA, he cared for complicated cancer patients with multiple medical problems at a Partners Healthcare Long Term Acute Care facility in Cambridge MA. As a member of the Ingo Mellinghoff lab at UCLA and later at Memorial Sloan Kettering Cancer Center in New York, he contributed to preclinical research into mechanisms of tumor resistance to targeted therapies, new metabolic inhibitors targeting a mutated version of the enzyme IDH, and treatment targets for lymphomas of the brain. An IDH inhibitor is now approved by the FDA for the treatment of relapsed and refractory acute myeloid leukemias. Pulse-dose lapatinib is currently being tested in a phase II clinical trial sponsored by the Jonson Comprehensive Cancer Center at UCLA in patients with an aggressive form of brain tumors and expected to be completed in 2019. The substantial activity of Ibrutinib in a phase I trial in relapsed and refractory brain lymphomas was reported in Cancer Discovery. Dr Palaskas is now interested in using metabolic interventions to improve the already promising activity of cancer immunotherapies.

(181) 899 - 5804

200 Medical Plaza Driveway Suite B265 (B2 Level),Los Angeles,CA

James Tomlinson, MD, PhD received his MD from the University of Pennsylvania School of Medicine in 1995. He was trained in General Surgery at UCLA, finishing in 2003. He also obtained his PhD degree in molecular biology at UCLA, and then completed a Surgical Oncology Fellowship at Memorial Sloan Kettering Cancer Center in 2005. Dr. Tomlinson has been Chief of Surgical Oncology, at the VA Greater Los Angeles Healthcare System Medical Center, Los Angeles, CA and Attending Surgeon in the Division of Surgical Oncology at UCLA since 2005. He has an active surgical oncology practice that is focused on pancreatic and biliary cancers. Dr. Tomlinson's basic science research efforts are focused on the development and evaluation of novel targeted imaging agents against pancreas cancer. Currently, he is evaluating the potential of Anti-CA19-9 and Anti-CEA engineered antibody fragments to serve as PET-imaging agents of pancreas cancer. He also performs outcomes research which addresses clinical questions in the management of pancreas cancer.

(131) 082 - 5621

100 Medical Plaza Suite 310,Los Angeles,CA

Download Dr. Baker's complete CV. Dr Jennifer L. Baker is a fellowship-trained breast surgical oncologist. She completed her general surgery training at University of California, San Diego and her fellowship in breast surgical oncology at Memorial Sloan Kettering Cancer Center in New York City. She is a Fellow of the American College of Surgeons. Dr. Baker's clinical specialties include oncoplastic breast surgery; skin and nipple sparing mastectomy; axillary surgery; inflammatory breast cancer…

(131) 082 - 5214

700 West 7th Street Suite S270,Los Angeles,CA

Dr. Birnstein received his undergraduate degree from the University of California, Berkeley and his medical degree from the Keck School of Medicine of USC. He completed his internship and residency in internal medicine at the Los Angeles County-USC Medical Center, where he served as chief resident. Dr. Birnstein completed his gastroenterology fellowship at Memorial Sloan Kettering Cancer Center in New York City, where he received specialized training in gastrointestinal complications of cancers…

(121) 340 - 9669

5400 Balboa Blvd Suite 228,Encino,CA

Suhail Salem, MD, is an experienced gastroenterologist offering specialized care at his practice in Northridge, California. Dr. Salem earned his medical degree at McGill University in Montreal, Canada, before completing internal medicine training at Rush University Medical Center in Chicago. During this time Dr. Salem served as chief resident and played an important role in training medical students and residents, which earned him an award for excellence in teaching and service. Dr. Salem stayed on at Rush University Medical Center to complete his fellowship in gastroenterology, where he received additional awards, including excellence in GI endoscopy and a Fellow of the Year. After finishing his fellowship, Dr. Salem pursued additional specialized training in advanced endoscopy at Memorial Sloan Kettering Cancer Center in New York City. He received dedicated training in endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP), in addition to other complex endoscopic techniques like endoscopic mucosal resection (EMR) and enteral stenting. He also gained extensive experience caring for patients with cancers affecting their GI tract. Dr. Salems clinical experience encompasses all aspects of gastroenterology and includes additional focus on using advanced endoscopic techniques to diagnose and manage a wide range of GI disorders. At his private practice in Northridge, Dr. Salem brings his advanced training and specialized skills to treating numerous GI conditions, including irritable bowel syndrome (IBS), hepatitis C, celiac disease, pancreatitis, gastroesophageal reflux disease (GERD), and constipation. Dr. Salems double board-certified in gastroenterology and internal medicine. Hes also a member of the American College of Gastroenterology and American Society for Gastrointestinal Endoscopy.

(181) 828 - 0596